SEC Form 4 · accession 0001035422-26-000012
CTT PHARMACEUTICAL HOLDINGS, INC. · CTTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
CTT PHARMACEUTICAL HOLDINGS, INC.
Officer — CEO · Director
Period of report
Sep 14, 2026
Accepted (ET)
Sep 16, 2026 · 1:19 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001035422
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| CTTH | Sep 16, 2026 | P | 10,900 | $0.048 | A | 9,414,456 | D |
Table II — derivative securities
No Table II lines on this filing.